首页 | 本学科首页   官方微博 | 高级检索  
     


Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation
Authors:Mostafa T. Mohammed  Songjie Cai  Benjamin L. Hanson  Hengcheng Zhang  Rachel L. Clement  Joe Daccache  Cecilia B. Cavazzoni  Bruce R. Blazar  Alessandro Alessandrini  Helmut G. Rennke  Anil Chandraker  Peter T. Sage
Affiliation:1. Clinical Pathology Department, Faculty of Medicine, Minia University, Minia, Egypt;2. Transplantation Research Center, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;3. Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota;4. Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts;5. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Abstract:
Following solid organ transplantation, a substantial proportion of chronic allograft loss is attributed to the formation of donor-specific antibodies (DSAs) and antibody-mediated rejection (AbMR). The frequency and phenotype of T follicular helper (Tfh) and T follicular regulatory (Tfr) cells is altered in the setting of kidney transplantation, particularly in patients who develop AbMR. However, the roles of Tfh and Tfr cells in AbMR after solid organ transplantation is unclear. We developed mouse models to inducibly and potently perturb Tfh and Tfr cells to assess the roles of these cells in the development of DSA and AbMR. We found that Tfh cells are required for both de novo DSA responses as well as augmentation of DSA following presensitization. Using orthotopic allogeneic kidney transplantation models, we found that deletion of Tfh cells at the time of transplantation resulted in less severe transplant rejection. Furthermore, using inducible Tfr cell deletion strategies we found that Tfr cells inhibit de novo DSA formation but only have a minor role in controlling kidney transplant rejection. These studies demonstrate that Tfh cells promote, whereas Tfr cells inhibit, DSA to control rejection after kidney transplantation. Therefore, targeting these cells represent a new therapeutic strategy to prevent and treat AbMR.
Keywords:alloantibody  animal models: murine  B cell biology  basic (laboratory) research / science  immune regulation  immunosuppression / immune modulation  kidney transplantation / nephrology
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号